TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TNF Pharmaceuticals ( (TNFA) ) has shared an announcement.
On September 2, 2025, TNF Pharmaceuticals announced a licensing agreement with LightSolver for a laser-based processing accelerator aimed at revolutionizing cryptocurrency applications. This strategic move positions TNF as a pioneer in light-based computing for blockchain, potentially reducing energy costs by up to 90%. Concurrently, TNF secured a $7 million private placement to fund its new venture, reflecting its shift towards innovative computing solutions and enhancing its market positioning.
More about TNF Pharmaceuticals
TNF Pharmaceuticals operates in the pharmaceutical industry, focusing on therapeutic platforms including TNF-alpha inhibitors and Supera-CBD. The company is now expanding into the cryptocurrency sector through a strategic partnership with LightSolver, acquiring exclusive rights to innovative laser-based computing technology for blockchain applications.
Average Trading Volume: 52,967,102
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.53M
Find detailed analytics on TNFA stock on TipRanks’ Stock Analysis page.